Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Personnel

CG Life Appoints Jon Sawyer as Chief Operating Officer to Support Strategic Growth and Integration


CG Life, a science-first, tech-enabled agency for life science, has expanded its leadership team to welcome Jon Sawyer as the agency's Chief Operating Officer. Sawyer brings more than 20 years of leadership in healthcare marketing to the role and will draw on this deep experience to manage CG Life's operations as the agency partners with established and emerging organizations in life sciences and biopharma.

"We continue to witness incredible scientific and medical innovation that has the potential for changing patients' lives. With the right team and strategy in place, CG Life will be there to shape and tell those stories," said CG Life CEO David Ormesher. "I know Jon well and have worked alongside him professionally for more than 20 years. His approachable, authentic, and pragmatic leadership will add tremendous value to our team as we continue to grow with purpose."

Most recently, Sawyer led closerlook inc., a digital marketing agency serving the pharmaceutical commercialization sector, as president and COO. With partner and founder David Ormesher, Sawyer drove the growth of closerlook into an award-winning technology and analytics-driven creative agency, which was ultimately acquired by Fishawack Health (now Avalere Health) in 2021. Sawyer then served as Fishawack's COO for US Commercial until April 2022.

Sawyer's appointment as COO comes at a pivotal time for CG Life. This past March, CG Life acquired Toolhouse, a well-respected digital agency for the life sciences. The acquisition has significantly expanded the agency's ability to support commercial life science organizations with digital omnichannel strategies.

"Life science marketers have the immense responsibility of turning scientific content and data into moving, impactful stories ? a responsibility the CG Life team takes very seriously. We're building upon a strong foundation of capabilities to deliver our clients the next-level support required for this next generation of technology," shared Sawyer. "I'm thrilled to join and lead such a talented, tight-knit group as we continue to experience and amplify some of science's most innovative breakthroughs yet."

As a dynamic team of nearly 150 digital marketing experts, scientific communicators, and PhD-level writers, CG Life provides integrated marketing solutions to leading companies in biopharma, medical devices, diagnostics, and research tools and services. The agency's recent brand refresh reflects the agency being "Shaped by Science" and demonstrates how the team works to guide brands and create compelling stories that connect to its clients, advance the industry at large, and inspire hope in the people who are confronted daily with healthcare challenges.

About CG Life

For more than two decades, CG Life has provided integrated marketing solutions to companies leading the way in therapeutics, medical devices, diagnostics, and research tools and services. Committed to the profound impact of science on everyday lives, CG Life blends scientific understanding with strategic imagination to guide clients through the biggest leaps they make.

Visit cglife.com to learn more.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: